A new study finds women taking GLP-1 Receptor agonists were significantly less likely to develop obesity-related cancers.

In a new study, researchers found no association between treatment with GLP-1 Receptor Agonists like Ozempic and Wegovy and increased risk of adverse psychiatric events.

A new study finds healthy adults using CGMs are getting info that could lead to harmful dietary choices.

A new study finds nearly half of people with type 2 diabetes suffer from multiple nutrient deficiencies

People who eat 5 servings per week of dark chocolate have a significantly lower risk of developing type 2 diabetes, according to researchers at Harvard.

A new study finds people diagnosed with type 2 diabetes before the age of 50 are nearly twice as likely to develop dementia compared to those diagnosed at 70. Researchers say the link is especially strong in those with obesity.

A new report from the CDC finds 15.8% of adults in the U.S. has Type 1 or Type 2 diabetes – and rates in men are higher than in women.

A new study finds women who experience frequent hot flashes and night sweats during the menopause transition have significantly higher odds of developing type 2 diabetes.

A new study finds type 2 diabetes patients taking semaglutide have much lower odds of developing Alzheimer’s disease, regardless of weight, gender or age.

Eating low-carb may help patients with mild type 2 diabetes recover function in their beta cells, which produce and release insulin, researchers say.

A new global study finds daily consumption of processed meat or unprocessed red meat significantly raises the odds of developing type 2 diabetes.

A new study finds GLP-1 medications like Ozempic and Wegovy are now being prescribed more often for obesity than type 2 diabetes.